Failure to publish trial results exposes patients to risks without providing benefits
9 hours ago
Turin, Italy: Although the publication of results of clinical trials carried out in the USA within 12 months of their completion has been mandatory since 2007, an astoundingly high number of Phase III radiotherapy trials ...
Novo Nordisk says US launch 'encouraging' as profit drops
20 hours ago
The world's largest maker of diabetes treatments, Novo Nordisk, said on Friday that the US launch of ultra-long acting insulin Tresiba had been "encouraging" as it reported a drop in first quarter profit.
Gilead 1Q profit tumbles on slower hepatitis C drug sales
Apr 28, 2016
Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.
Cardiovascular giants Abbott, St. Jude in $25 bn merger
Apr 28, 2016
Abbott Laboratories and St. Jude Medical, leading makers of heart care and coronary devices, announced a $25 billion merger Thursday to better target the rising levels of cardiovascular disease in aging populations.
GSK sees rise in sales of vaccines, healthcare products
Apr 27, 2016
Pharmaceutical company GlaxoSmithKline says higher sales of vaccines and consumer healthcare products pushed up its earnings from core business by 19 percent in the first quarter.
Michigan nursing school uses mannequins for medical lessons
Apr 26, 2016
The leadership at the University of Michigan's nursing school says there is value in students making mistakes while treating patients.
First-degree relative grafts don't up liver disease recurrence
Apr 25, 2016
(HealthDay)—In liver transplantation (LT), patients who receive living donor grafts from first-degree relatives due to autoimmune liver diseases are not prone to increased disease recurrence, compared to those who receive ...
Valeant names new chief executive
Apr 25, 2016
Embattled Canadian pharmaceutical company Valeant named as its new chief executive and chairman on Monday Joseph Papa, who has left his post leading Perrigo, a maker of over-the-counter medical products.
The rise and fall of Theranos—so many lessons in a drop of blood
Apr 22, 2016
The last few months have witnessed the unraveling of the remarkable life sciences company Theranos, culminating in the latest news that federal regulators may ban founder Elizabeth Holmes from the blood-testing industry for ...
Should the food industry fund health research?
Apr 20, 2016
In The BMJ today, leading experts debate whether the food industry should fund health research, and if so, under what circumstances.